Rosetta Genomics (ROSG) Mesothelioma Joint Study with NYU Langone Med Center To Be Published
Tweet Send to a Friend
Rosetta Genomics, Ltd. (NASDAQ: ROSG) announced today that the results of a joint study with the NYU Langone Medical Center ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
